While our current experiments focus on TXNIP induction by RocA, our previous work demonstrated that a slightly acidic pH of ~ 6.7 drives a gene signature that correlates with good clinical prognosis in breast cancer, and TXNIP is a component of that signature [44]. Here, TXNIP is linked to breast carcinoma.